Premium
Flutamide in the Treatment of Metastatic Carcinoma of the Prostate
Author(s) -
NARAYANA A. S.,
LOENING S. A.,
CULP D. A.
Publication year - 1981
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1981.tb03157.x
Subject(s) - flutamide , medicine , nausea , prostate , prostate carcinoma , vomiting , metastatic carcinoma , urology , carcinoma , oncology , prostate cancer , cancer , androgen receptor
SUMMARY— Twenty‐five patients with metastatic carcinoma of the prostate were treated with Flutamide, a non‐steroidal anti‐androgen. All patients showed progression; the longest response was 1 20 weeks. The side effects were nausea, vomiting, breast tenderness and gynaecomastia.